Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches

The prevalence of Alzheimer’s disease (AD) has been a major health concern for a long time. Despite recent progress, there is still a strong need to develop effective disease-modifying therapies. Several drugs have already been approved to retard the progression of AD-related symptoms; however, ther...

Full description

Bibliographic Details
Main Authors: Rashid Waseem, Anas Shamsi, Tanzeel Khan, Md. Imtaiyaz Hassan, Syed Naqui Kazim, Mohammad Shahid, Asimul Islam
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/11/5965
_version_ 1797493260630884352
author Rashid Waseem
Anas Shamsi
Tanzeel Khan
Md. Imtaiyaz Hassan
Syed Naqui Kazim
Mohammad Shahid
Asimul Islam
author_facet Rashid Waseem
Anas Shamsi
Tanzeel Khan
Md. Imtaiyaz Hassan
Syed Naqui Kazim
Mohammad Shahid
Asimul Islam
author_sort Rashid Waseem
collection DOAJ
description The prevalence of Alzheimer’s disease (AD) has been a major health concern for a long time. Despite recent progress, there is still a strong need to develop effective disease-modifying therapies. Several drugs have already been approved to retard the progression of AD-related symptoms; however, there is a need to develop an effective carrier system for the delivery of drugs to combat such diseases. In recent years, various biological macromolecules, including proteins, have been used as carriers for drug delivery. Irisin is a beneficial hormone in such diseases, including AD and related pathologies. Herein, the interaction mechanism of irisin with AD drugs such as memantine, galantamine, and fluoxetine is investigated. Fluorescence studies revealed that the above drugs bind to irisin with significant affinity, with fluoxetine having the highest binding affinity. Isothermal titration calorimetry (ITC) complemented the spontaneous binding of these drugs with irisin, delineating various associated thermodynamic and binding parameters. Molecular docking further validated the fluorescence and ITC results and unfolded the mechanism that hydrogen bonding governs the binding of fluoxetine to irisin with a significant binding score, i.e., −6.3 kcal/mol. We believe that these findings provide a promising solution to fight against AD as well as a platform for further research to utilize irisin in the drug-delivery system for an effective therapeutic strategy.
first_indexed 2024-03-10T01:17:28Z
format Article
id doaj.art-ca29edd492a5440a829f4571e384fab9
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T01:17:28Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ca29edd492a5440a829f4571e384fab92023-11-23T14:07:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-05-012311596510.3390/ijms23115965Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational ApproachesRashid Waseem0Anas Shamsi1Tanzeel Khan2Md. Imtaiyaz Hassan3Syed Naqui Kazim4Mohammad Shahid5Asimul Islam6Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, IndiaCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, IndiaCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, IndiaCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, IndiaCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, IndiaDepartment of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi ArabiaCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, IndiaThe prevalence of Alzheimer’s disease (AD) has been a major health concern for a long time. Despite recent progress, there is still a strong need to develop effective disease-modifying therapies. Several drugs have already been approved to retard the progression of AD-related symptoms; however, there is a need to develop an effective carrier system for the delivery of drugs to combat such diseases. In recent years, various biological macromolecules, including proteins, have been used as carriers for drug delivery. Irisin is a beneficial hormone in such diseases, including AD and related pathologies. Herein, the interaction mechanism of irisin with AD drugs such as memantine, galantamine, and fluoxetine is investigated. Fluorescence studies revealed that the above drugs bind to irisin with significant affinity, with fluoxetine having the highest binding affinity. Isothermal titration calorimetry (ITC) complemented the spontaneous binding of these drugs with irisin, delineating various associated thermodynamic and binding parameters. Molecular docking further validated the fluorescence and ITC results and unfolded the mechanism that hydrogen bonding governs the binding of fluoxetine to irisin with a significant binding score, i.e., −6.3 kcal/mol. We believe that these findings provide a promising solution to fight against AD as well as a platform for further research to utilize irisin in the drug-delivery system for an effective therapeutic strategy.https://www.mdpi.com/1422-0067/23/11/5965irisinmolecular dockingfluorescence spectroscopydrug deliveryAlzheimer’s diseaseisothermal titration calorimetry
spellingShingle Rashid Waseem
Anas Shamsi
Tanzeel Khan
Md. Imtaiyaz Hassan
Syed Naqui Kazim
Mohammad Shahid
Asimul Islam
Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
International Journal of Molecular Sciences
irisin
molecular docking
fluorescence spectroscopy
drug delivery
Alzheimer’s disease
isothermal titration calorimetry
title Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
title_full Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
title_fullStr Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
title_full_unstemmed Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
title_short Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
title_sort unraveling the binding mechanism of alzheimer s drugs with irisin spectroscopic calorimetric and computational approaches
topic irisin
molecular docking
fluorescence spectroscopy
drug delivery
Alzheimer’s disease
isothermal titration calorimetry
url https://www.mdpi.com/1422-0067/23/11/5965
work_keys_str_mv AT rashidwaseem unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches
AT anasshamsi unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches
AT tanzeelkhan unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches
AT mdimtaiyazhassan unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches
AT syednaquikazim unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches
AT mohammadshahid unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches
AT asimulislam unravelingthebindingmechanismofalzheimersdrugswithirisinspectroscopiccalorimetricandcomputationalapproaches